• Login
Thursday, March 5, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Business

Terns Pharmaceuticals CMO Kuriakose sells $44,552 in stock

GenevaTimes by GenevaTimes
January 7, 2026
in Business
Reading Time: 1 min read
0
Terns Pharmaceuticals CMO Kuriakose sells ,552 in stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter



Terns Pharmaceuticals CMO Kuriakose sells $44,552 in stock
Terns Pharmaceuticals CMO Kuriakose sells $44,552 in stock

Read More

Previous Post

Venezuelan security forces detain journalists from foreign news organisations

 Next Post

Tajikistan’s economic future looks bright with strong growth projections – CEBR
Next Post
Tajikistan’s economic future looks bright with strong growth projections – CEBR

Tajikistan’s economic future looks bright with strong growth projections - CEBR

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin